Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue 8
Submit an article Journal homepage
354
Views
5
CrossRef citations to date
0
Altmetric
Neurology

Relative performance of brivaracetam as adjunctive treatment of focal seizures in adults: a network meta-analysis

Mata CharokopouUCB Pharma, Brussels, Belgium; Correspondence[email protected]
,
Rebecca HarveyBresMed Health Solutions Ltd, Sheffield, UK;
,
Kunal SrivastavaBresMed India, Gurugram, Haryana, India;
,
Christian BrandtDepartment of General Epileptology, Bethel Epilepsy Centre, Mara Hospital, Bielefeld, Germany;
&
Simon BorghsUCB Pharma, Slough, Berkshire, UK
Pages 1345-1354 | Received 14 Feb 2018, Accepted 10 Jan 2019, Published online: 27 Mar 2019

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Isabel Barrachina-Martinez, David Vivas-Consuelo & Francisco Reyes-Santias. (2021) Cost-utility model of brivaracetam in the adjunctive treatment of patients with epilepsy in Spain. Expert Review of Pharmacoeconomics & Outcomes Research 21:5, pages 1081-1090.
Read now

Articles from other publishers (4)

Christian Brandt & Roland Seifert. 2023. Arzneiverordnungs-Report 2023. Arzneiverordnungs-Report 2023 553 567 .
Roland Seifert & Christian Brandt. 2022. Arzneiverordnungs-Report 2022. Arzneiverordnungs-Report 2022 519 532 .
Brian D. Moseley, Hugues Chanteux, Jean-Marie Nicolas, Cédric Laloyaux, Barry Gidal & Armel Stockis. (2020) A review of the drug−drug interactions of the antiepileptic drug brivaracetam. Epilepsy Research 163, pages 106327.
Crossref
Saku Väätäinen, Erkki Soini, Jukka Peltola, Mata Charokopou, Maarit Taiha & Reetta Kälviäinen. (2019) Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland. Advances in Therapy 37:1, pages 477-500.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.